2011, Number 4
Aspirin desensitization in a patient who exhibit intolerance to non-steroidal anti-inflammatories
Language: Spanish
References: 17
Page: 597-603
PDF size: 44.72 Kb.
ABSTRACT
Aspirine is one of the most widely used drugs worldwide. The patients suffering from heart diseases require long-term treatment with this drug, which is banned to those having adverse reactions. The international literature collects information on the use of desensitization therapies in patients who do not exhibit tolerance to this medicine, following different protocols with satisfactory results. This paper described the first aspirin desensitization procedure, which was performed at «Calixto García» university hospital, and the performance protocol. There was not any other case of this type reported in the national literature. The patient can presently take 125 mg of aspirin daily without suffering adverse events. It was considered that the desensitization process is an effective therapeutic action for patients who are aspirin sensitive and who have specific diseases that warrant this procedure.REFERENCES
Dalmau G, Gaig P, Gázquez V y Mercé J. Desensibilización rápida al ácido acetilsalicílico en pacientes con intolerancia a AINE afectos de síndrome coronario agudo. Rev Esp Cardiol [Internet]. 2009 [citado 10 de May 2011]; 62(2):224-30. Disponible en: http://www.revespcardiol.org/es/revistas/revista-espa%C3%B1olacardiologia-25/desensibilizacion-rapida-al -acido-acetilsalicilico-pacientes-intolerancia-13132057-cartas-al-editor-2009
A. Rozsasi D, Polzehl T, Deutschle E, Smith K, Wiesmiller H. Riechelmann, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy [Internet]. 2008 [cited 2011 May 12]; 63:1228-34. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2008.01658.x/full
Wong JT, Nagy CS, Krinzman SJ, Maclean JA, Bloch KJ. Rapid oral challengedesensitization for patients with aspirin related urticaria-angioedema. J Allergy Clin Immunol [Internet]. 2000 [cited 2011 May 12]; 105:997-1001. Available from: http://www.jacionline.org/article/S0091-6749%2800%2980024-X/fulltext
Ortega-Loayza AG, Raza S, Minisi AJ, Topaz O, Heller A, Jovin I. Aspirin Desensitization/Challenge in 3 Patients With Unstable Angina. Am J Med Sci [Internet]. 2010 [cited 2011 Apr 12]; 340(5):418-20. Available from: http://journals.lww.com/amjmedsci/Abstract/2010/11000/Aspirin_Desensitization_Challenge_in_3_Patients.18.aspx
AL De Weck, ML Sanz, Gamboa PM, Aberer W, Blanca M, Correia S, et al. Nonsteroidal Anti-inflammatory Drug Hypersensitivity Syndrome. A Multicenter Study. Clinical Findings and in vitro Diagnosis. J Investig Allergol Clin Immunol [Internet]. 2009 [cited 2011 Mar 12]; 19(5):355-69. Available from: http://www.jiaci.org/issues/vol19issue5/2.pdf
Cardona R, Ramírez RH, Reina Z, Escobar M F, Morales E. Alergia e intolerancia a antiinflamatorios no esteroideos: desensibilización exitosa en tres casos y revisión de la literatura. Biomédica [Internet]. 2009 [citado 21 May 2011]; 29;181-90. Disponible en: http://www.scielo.org.co/pdf/bio/v29n2/v29n2a03.pdf
Shaker M, Lobb A, Jenkins P, O'Rourke D, Takemoto SK, Sheth S, Burroughs T, Dykewicz MS. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol [Internet]. 2008 [cited 2011 Mar 12]; 121:81-7. Available from: http://www.jacionline.org/article/S0091-